Pain Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PTIE and buy or sell other stocks, ETFs, and their options commission-free!About PTIE
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx.
CEORichard Jon Barry
CEORichard Jon Barry
Employees—
Employees—
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded1998
Founded1998
Employees—
Employees—
PTIE Key Statistics
Market cap141.54M
Market cap141.54M
Price-Earnings ratio-1.33
Price-Earnings ratio-1.33
Dividend yield—
Dividend yield—
Average volume760.62K
Average volume760.62K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.98
52 Week high$4.98
52 Week low$1.15
52 Week low$1.15
Stock Snapshot
As of today, Pain Therapeutics(PTIE) shares are valued at $6.01. The company's market cap stands at 141.54M, with a P/E ratio of -1.33.
On 2025-12-14, Pain Therapeutics(PTIE) stock opened at —, reached a high of —, and a low of —.
The Pain Therapeutics(PTIE)'s current trading volume is 0, compared to an average daily volume of 760.62K.
During the past year, Pain Therapeutics(PTIE) stock moved between $1.15 at its lowest and $4.98 at its peak.
During the past year, Pain Therapeutics(PTIE) stock moved between $1.15 at its lowest and $4.98 at its peak.